Raphael Pharmaceutical (RAPH) Debt Ratio (2020 - 2025)

Raphael Pharmaceutical (RAPH) has 5 years of Debt Ratio data on file, last reported at 1.28 in Q4 2025.

• For the quarter ending Q4 2025, Debt Ratio fell 87.12% year-over-year to 1.28; the trailing twelve-month figure through Dec 2025 stood at 1.28 (down 87.12% YoY), and the FY2025 full-year result was 1.28, down 87.12% from the prior year.
• Debt Ratio slipped to 1.28 in Q4 2025, from 5.86 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 9.96 in Q4 2024 to a low of 0.01 in Q1 2022.
• A 4-year average of 2.12 and a median of 0.44 in 2025 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio surged 87.1% in 2021 and slumped 87.12% in 2025, its largest moves.
• Tracing RAPH's Debt Ratio over 4 years: stood at 0.05 in 2021, then tumbled by 82.72% to 0.01 in 2022, then surged by 110488.89% to 9.96 in 2024, then tumbled by 87.12% to 1.28 in 2025.
• Business Quant data shows RAPH's Debt Ratio at 1.28 in Q4 2025, 5.86 in Q3 2025, and 1.37 in Q2 2025.